

Moderna Begins Clinical Trials of Bundibugyo Ebola Virus Vaccine
The American biotechnology company Moderna has begun Phase I clinical trials of a vaccine against the Bundibugyo Ebola virus. The first volunteers have already received the experimental vaccine
















